HomeCompareVAPO vs JEPI

VAPO vs JEPI: Dividend Comparison 2026

VAPO yields 92.17% · JEPI yields 8.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VAPO wins by $2.78M in total portfolio value
10 years
VAPO
VAPO
● Live price
92.17%
Share price
$2.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.81M
Annual income
$897,478.47
Full VAPO calculator →
JEPI
JPMorgan Equity Premium Income ETF
● Live price
8.40%
Share price
$56.68
Annual div
$4.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$1,528.62
Full JEPI calculator →

Portfolio growth — VAPO vs JEPI

📍 VAPO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVAPOJEPI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VAPO + JEPI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VAPO pays
JEPI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VAPO
Annual income on $10K today (after 15% tax)
$7,834.10/yr
After 10yr DRIP, annual income (after tax)
$762,856.70/yr
JEPI
Annual income on $10K today (after 15% tax)
$714.16/yr
After 10yr DRIP, annual income (after tax)
$1,299.33/yr
At 15% tax rate, VAPO beats the other by $761,557.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VAPO + JEPI for your $10,000?

VAPO: 50%JEPI: 50%
100% JEPI50/50100% VAPO
Portfolio after 10yr
$1.42M
Annual income
$449,503.54/yr
Blended yield
31.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VAPO right now

VAPO
Analyst Ratings
2
Buy
3
Hold
1
Sell
Consensus: Hold
Price Target
$1.60
-26.3% upside vs current
Range: $1.60 — $1.60
Altman Z
-14.2
Piotroski
4/9
JEPI
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VAPO buys
0
JEPI buys
0
No recent congressional trades found for VAPO or JEPI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVAPOJEPI
Forward yield92.17%8.40%
Annual dividend / share$2.00$4.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$2.81M$29.0K
Annual income after 10y$897,478.47$1,528.62
Total dividends collected$2.49M$11.7K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: VAPO vs JEPI ($10,000, DRIP)

YearVAPO PortfolioVAPO Income/yrJEPI PortfolioJEPI Income/yrGap
1← crossover$19,917$9,216.59$11,260$840.19+$8.7KVAPO
2$38,466$17,155.42$12,641$907.94+$25.8KVAPO
3$72,125$30,965.76$14,150$978.20+$58.0KVAPO
4$131,436$54,262.79$15,795$1,050.85+$115.6KVAPO
5$233,053$92,416.55$17,584$1,125.74+$215.5KVAPO
6$402,513$153,146.25$19,526$1,202.74+$383.0KVAPO
7$677,889$247,199.53$21,628$1,281.69+$656.3KVAPO
8$1,114,424$389,082.88$23,898$1,362.43+$1.09MVAPO
9$1,790,226$597,792.36$26,347$1,444.79+$1.76MVAPO
10$2,813,020$897,478.47$28,982$1,528.62+$2.78MVAPO

VAPO vs JEPI: Complete Analysis 2026

VAPOStock

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Full VAPO Calculator →

JEPIETF

The fund seeks to provide the majority of the returns associated with its primary benchmark, the Standard & Poor's 500 Total Return Index (S&P 500 Index), while exposing investors to less risk through lower volatility and still offering incremental income. Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It may also invest in other equity securities not included in the S&P 500 Index.

Full JEPI Calculator →
📬

Get this VAPO vs JEPI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VAPO vs SCHDVAPO vs OVAPO vs KOVAPO vs MAINVAPO vs JEPQVAPO vs XYLDVAPO vs DIVOVAPO vs QYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.